11 | NetworkNewsBreaks AnPac Bio-Medical Science | NetworkNewsWire | 08/17/2021 4:46:12 PM |
10 | Anpac Bio Continues Growth Trajectory In recent | NetworkNewsWire | 08/12/2021 4:49:51 PM |
9 | NetworkNewsBreaks Why AnPac Bio-Medical | NetworkNewsWire | 08/11/2021 4:13:04 PM |
8 | AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) | NetworkNewsWire | 08/06/2021 5:08:11 PM |
7 | NetworkNewsBreaks AnPac Bio-Medical Science | NetworkNewsWire | 08/05/2021 4:25:02 PM |
6 | AnPac Bio-Science Co., Ltd. Continues To Build On | NetworkNewsWire | 08/04/2021 4:09:01 PM |
5 | AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) | NetworkNewsWire | 08/02/2021 3:24:57 PM |
4 | ANPC 48% v43M c8.61 f11,2M preMH12.6 HOD12.09 gap | znewcar1 | 03/09/2021 4:39:45 PM |
3 | ANPC 35% v30,8M c5.70 f11,2M H8.65 preMH10.1 gap | znewcar1 | 12/14/2020 5:08:31 PM |
2 | ANPC 104% v40,7M c7.14 f11,2M preMH9.2 S6.3 | znewcar1 | 11/25/2020 4:12:38 PM |
1 | ANPC 22% v19,1M c3.92 f11,2M preMH5.07 | znewcar1 | 11/02/2020 9:12:59 PM |
Recent Articles
- PRIO Luxembourg Holding's Recent Cash Tender Offer Results
- Fossil Group Extends Senior Notes Exchange Offer Deadline
- Quantum BioPharma Offers $7 Million Reward for Stock Fraud Tips
- Helport AI and Atome Strengthen Partnership for Remarkable Growth
- Vaxart to Unveil Breakthrough Oral Pill Vaccines at Congress
- Jyske Realkredit Announces New Interest Rate Adjustment Date
- Advanced Tactical Solutions Highlighted by Trace Systems
- Science 37's Latest FDA Approval Boosts Clinical Trial Access
- Leidos Partners with Kazakhstan to Enhance Air Traffic Control
- Gary Huff Joins Biomerica's Board, Aiming to Boost Growth
- Regent Hong Kong Celebrates Top Rankings in Global Awards
- Raytheon's SPY-6(V)1 Radar Chosen for German Navy Frigates
- Myseum Unveils New Social Sharing Platform and Progress Updates
- Settlement for Vanguard Target Retirement Fund Investors Announced
- Empowering Military Spouses Through Career Summit Innovations
- EXL to Announce Third Quarter Financial Results Soon
- Empowering Workplace Mental Health Initiatives at meQuilibrium
- Top Utility Stocks Offering Strong Dividend Yields to Investors
- Bitcoin Life Insurer's $82M Funding Boosts Inflation-Proof Solutions
- Discovering New Opportunities in Shares of Conagra and EQT
- Kahua Enhances UK Footprint with Cybersecurity Success
- The Gold Surge and Its Impact on Sprott ETFs: Insights
- Senate Declares National WWII Italian Campaign Remembrance Day
- Innovative EcoRecord® Revolutionizes Sustainable LP Production
- Discover the New Savory Bacon Macaroni & Cheese Delight
- Strategic Merger Announcement between NB Bancorp and Provident
- Unlocking AI's Potential: Insights from JB Baker at ScaleFlux
- Sentral Expands Multifamily Management Ventures in Texas and Bay Area
- Thunder and Partners Launch Visionary AI Research Lab for Students
- Rocket Doctor Expands Insurance Coverage for Millions of Patients
- Transforming Hiring Efficiency: Hirevue's New AI Features
- DYWIDAG Strengthens Southeast U.S. Presence for Concrete Solutions
- New Insurance Program Tailored for Anesthesiologists Launched
- Coral Vita Champions Ocean Restoration at NYC Climate Week
- Leadership Changes in World Services Group Board for 2025-2026
- Nasus Pharma Expands Development Agreement for NS002 Product
- Monogram Health Elevates Leadership for Future Growth and Care
- Anticipated Growth of the LED Video Wall Market to $33.87 Billion
- Exploring the Digital Healthcare Education Market Growth
- Visier Triumphs as a Leader in AI-Driven HR Solutions
- Enovis Completes Strategic Sale of Dr. Comfort for $60 Million
- AI-Driven Development Forces Reassessment of Security Practices
- Penguin Solutions Earnings: Key Insights and Market Movements
- Blue Foundry Bancorp Announces Upcoming Earnings Conference Call
- Revolutionizing Beauty: Hyper-Bond Serum Foundation Unveiled
- Prenetics Unveils Daily Ultimate Longevity with New Formula
- AiPrise Secures $12.5 Million to Transform Global Compliance
- Nasus Pharma Partners with Aptar for NS002 Epinephrine Advancements
- Apple And Meta Close In On Settlement With EU Regulators
- Boehringer Ingelheim Expands Oncology Portfolio with New Asset